PRSS1 Upregulation Predicts Platinum Resistance in Ovarian Cancer Patients

Ovarian cancer is the most frequent cause of death among gynecologic malignancies. A total of 80% of patients who have completed platinum-based chemotherapy suffer from relapse and develop resistance within 2 years. In the present study, we obtained patients' complete platinum (cisplatin and ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Linan, Tian, Songyu, Mi, Wanqi, Zhang, Yongjian, Zhang, Yunyan, Zhang, Yuxi, Xu, Fengye, Zhang, Chunlong, Lou, Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876278/
https://www.ncbi.nlm.nih.gov/pubmed/33585454
http://dx.doi.org/10.3389/fcell.2020.618341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876278/
https://www.ncbi.nlm.nih.gov/pubmed/33585454
http://dx.doi.org/10.3389/fcell.2020.618341

Ejemplares similares